Chemotherapy - kashubian

Drug or Chemo Therapy Associated with Adenocarcinoma, Stomach Cancer. Posted on October 17, 2015 View this journey (49 Experiences)

Ibrance (Palbociclib) is the treatment that matches his mutation, a CDK 4 amplification. Newly approved just months ago (Feb 2015), it is very expensive. We are currently waiting to see if Medicare will pay (he had to go on Medicare after 2 years on disability), hoping the MD Anderson genome report will bolster our case for why we want this expensive treatment. If Medicare won't cover this therapy, we have a few other avenues to explore. Praying.

Easy to Do: Not Specified
Minimal Side Effects: Not Specified
Minimal Impact to Daily Life: Not Specified

Read more Adenocarcinoma, Stomach Cancer experiences about Chemotherapy.

Read and answer Adenocarcinoma, Stomach Cancer questions.